Endoscopy 2012; 44(11): 1055-1058
DOI: 10.1055/s-0032-1325733
Case report/series
© Georg Thieme Verlag KG Stuttgart · New York

Secondary sclerosing cholangitis in critically ill patients: Model of End-Stage Liver Disease score and renal function predict outcome

T. Voigtländer
1   Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany
,
A. A. Negm
1   Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany
,
A. S. Schneider
1   Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany
,
C. P. Strassburg
1   Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany
,
M. P. Manns
1   Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany
2   Integrated Research and Treatment Center – Transplantation (IFB-Tx), Hannover Medical School, Hannover, Germany
,
J. Wedemeyer*
1   Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany
2   Integrated Research and Treatment Center – Transplantation (IFB-Tx), Hannover Medical School, Hannover, Germany
,
T. O. Lankisch
1   Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany
2   Integrated Research and Treatment Center – Transplantation (IFB-Tx), Hannover Medical School, Hannover, Germany
› Author Affiliations
Further Information

Publication History

submitted 24 January 2012

accepted after revision 23 July 2012

Publication Date:
29 October 2012 (online)

Secondary sclerosing cholangitis in critically ill patients (SSC – CIP) is an underdiagnosed emerging disease. The aim of this study was to characterize clinical features and prognostic factors for mortality in SSC – CIP. This retrospective study included 54 patients who were diagnosed via endoscopic retrograde cholangiopancreatography (ERCP) after cardiothoracic surgery (n = 21), sepsis (n = 13), polytrauma (n = 11), and others (n = 9). In total, 33 patients who either died (n = 27) or needed liver transplantation (n = 6) were compared with surviving patients (n = 21). The model for end-stage liver disease (MELD) score and need for renal replacement therapy were independent risk factors for mortality. Compared with ERCP, accuracy was 30 % for ultrasound and 36 % for liver biopsies. As a result of microbiological bile analysis, 28 % of patients required a change in antibiotic treatment. SSC – CIP is frequently a fatal disease. ERCP should be considered in selected patients to establish the diagnosis and hence provide useful clinical information.

* Current address: Medical Department I, Robert Koch Hospital Gehrden, Gehrden, Germany.


 
  • References

  • 1 Engler S, Elsing C, Flechtenmacher C et al. Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders. Gut 2003; 52: 688-693
  • 2 Jaeger C, Mayer G, Henrich R et al. Secondary sclerosing cholangitis after long-term treatment in an intensive care unit: clinical presentation, endoscopic findings, treatment, and follow-up. Endoscopy 2006; 38: 730-734
  • 3 Gelbmann CM, Rummele P, Wimmer M et al. Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol 2007; 102: 1221-1229
  • 4 Kulaksiz H, Heuberger D, Engler S et al. Poor outcome in progressive sclerosing cholangitis after septic shock. Endoscopy 2008; 40: 214-218
  • 5 Negm AA, Schott A, Vonberg RP et al. Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc 2010; 72: 284-291
  • 6 Deltenre P, Valla DC. Ischemic cholangiopathy. Semin Liver Dis 2008; 28: 235-246
  • 7 Parry SD, Muiesan P. Cholangiopathy and the biliary cast syndrome. Eur J Gastroenterol Hepatol 2003; 15: 341-343
  • 8 Esposito I, Kubisova A, Stiehl A et al. Secondary sclerosing cholangitis after intensive care unit treatment: clues to the histopathological differential diagnosis. Virchows Arch 2008; 453: 339-345
  • 9 Kobayashi S, Nakanuma Y, Matsui O. Intrahepatic peribiliary vascular plexus in various hepatobiliary diseases: a histological survey. Hum Pathol 1994; 25: 940-946
  • 10 Batts KP. Ischemic cholangitis. Mayo Clin Proc 1998; 73: 380-385